Idera Pharmaceuticals - 48 Year Dividend Yield History | IDRA

Historical dividend payout and yield for Idera Pharmaceuticals (IDRA) since 1971. The current TTM dividend payout for Idera Pharmaceuticals (IDRA) as of February 22, 2019 is $0.00. The current dividend yield for Idera Pharmaceuticals as of February 22, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.072B $0.001B
Idera Pharmaceuticals, Inc. is a drug discovery and development company that is developing drug candidates to treat cancer and infectious, respiratory, and autoimmune diseases, and for use in combination with therapeutic and prophylactic vaccines. Idera's proprietary drug candidates are designed to modulate Toll-like Receptors, the body's first line of immune defense. Idera's pioneering DNA chemistry expertise enables it to identify drug candidates for internal development and creates opportunities for multiple collaborative alliances.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.316B 12.97
Gilead Sciences (GILD) United States $86.647B 10.87
Bio-Techne Corp (TECH) United States $7.316B 49.29